Contact this trialFirst, we need to learn more about you.
Histone Deacetylase Inhibitor
TAS1440 + ATRA for Leukemia
Recruiting1 awardPhase 1
Ann Arbor, Michigan
This trial is testing a new drug called TAS1440, alone and with ATRA, in patients with AML who didn't respond to previous treatments or whose cancer returned. It aims to see how the drug works in the body and if it can help treat the leukemia. Bisantrene, a new drug, has shown positive effects in earlier studies with manageable side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service